Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 225

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

A Validated Model for Sudden Cardiac Death Risk Prediction in Pediatric Hypertrophic Cardiomyopathy

Open access
Miron, Anastasia, Lafreniere-Roula, Myriam, Steve Fan, Chun-Po, Armstrong, Katey R., Dragulescu, Andreea, Papaz, Tanya, Manlhiot, Cedric, Kaufman, Beth, Butts, Ryan J., Gardin, Letizia, Stephenson, Elizabeth A., Howard, Taylor S., Aziz, Pete F., Balaji, Seshadri, Ladouceur, Virginie Beauséjour, Benson, Lee N., Colan, Steven D., Godown, Justin, Henderson, Heather T., Ingles, Jodie, Jeewa, Aamir, Jefferies, John L., Lal, Ashwin K., Mathew, Jacob, Jean-St-Michel, Emilie, Michels, Michelle, Nakano, Stephanie J., Olivotto, Iacopo, Parent, John J., Pereira, Alexandre C., Semsarian, Christopher, Whitehill, Robert D., Wittekind, Samuel G., Russell, Mark W., Conway, Jennifer, Richmond, Marc E., Villa, Chet, Weintraub, Robert G., Rossano, Joseph W., Kantor, Paul F., Ho, Carolyn Y., Mital, Seema·2020·Circulation

Abstract

Background: Hypertrophic cardiomyopathy is the leading cause of sudden cardiac death (SCD) in children and young adults. Our objective was to develop and validate a SCD risk prediction model in pediatric hypertrophic cardiomyopathy to guide SCD prevention strategies. Methods: In an international multicenter observational cohort study, phenotype-positive patients with isolated hypertrophic cardiomyopathy <18 years of age at diagnosis were eligible. The primary outcome variable was the time from diagnosis to a composite of SCD events at 5-year follow-up: SCD, resuscitated sudden cardiac arrest, and aborted SCD, that is, appropriate shock following primary prevention implantable cardioverter defibrillators. Competing risk models with cause-specific hazard regression were used to identify and quantify clinical and genetic factors associated with SCD. The cause-specific regression model was implemented using boosting, and tuned with 10 repeated 4-fold cross-validations. The final model was fitted using all data with the tuned hyperparameter value that maximizes the c-statistic, and its performance was characterized by using the c-statistic for competing risk models. The final model was validated in an independent external cohort (SHaRe [Sarcomeric Human Cardiomyopathy Registry], n=285). Results: Overall, 572 patients met eligibility criteria with 2855 patient-years of follow-up. The 5-year cumulative proportion of SCD events was 9.1% (14 SCD, 25 resuscitated sudden cardiac arrests, and 14 aborted SCD). Risk predictors included age at diagnosis, documented nonsustained ventricular tachycardia, unexplained syncope, septal diameter z -score, left ventricular posterior wall diameter z score, left atrial diameter z score, peak left ventricular outflow tract gradient, and presence of a pathogenic variant. Unlike in adults, left ventricular outflow tract gradient had an inverse association, and family history of SCD had no association with SCD. Clinical and clinical/genetic models were developed to predict 5-year freedom from SCD. Both models adequately discriminated between patients with and without SCD events with a c-statistic of 0.75 and 0.76, respectively, and demonstrated good agreement between predicted and observed events in the primary and validation cohorts (validation c-statistic 0.71 and 0.72, respectively). Conclusion: Our study provides a validated SCD risk prediction model with >70% prediction accuracy and incorporates risk factors that are unique to pediatric hypertrophic cardiomyopathy. An individualized risk prediction model has the potential to improve the application of clinical practice guidelines and shared decision making for implantable cardioverter defibrillator insertion. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT0403679.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circulationaha.120.047235

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 225

Metadata

Authors
Miron, A., Lafreniere-Roula, M., Steve Fan, C.-P., Armstrong, K. R., Dragulescu, A., Papaz, T., Manlhiot, C., Kaufman, B., Butts, R. J., Gardin, L., Stephenson, E. A., Howard, T. S., Aziz, P. F., Balaji, S., Ladouceur, V. B., Benson, L. N., Colan, S. D., Godown, J., Henderson, H. T., Ingles, J., Jeewa, A., Jefferies, J. L., Lal, A. K., Mathew, J., Jean-St-Michel, E., Michels, M., Nakano, S. J., Olivotto, I., Parent, J. J., Pereira, A. C., Semsarian, C., Whitehill, R. D., Wittekind, S. G., Russell, M. W., Conway, J., Richmond, M. E., Villa, C., Weintraub, R. G., Rossano, J. W., Kantor, P. F., Ho, C. Y., & Mital, S.
Venue
Circulation
Published
2020-07-21
Volume
142
Issue
3
Pages
217-229
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W3024147252
Cited by
225
References
2
FWCI
17.18
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Validated Model for Sudden Cardiac Death Risk Prediction in Pediatric Hypertrophic Cardiomyopathy. https://app.cochat.ai/papers/10.1161/circulationaha.120.047235
The paper
Miron, A., Lafreniere-Roula, M., Steve Fan, C.-P., Armstrong, K. R., Dragulescu, A., Papaz, T., Manlhiot, C., Kaufman, B., Butts, R. J., Gardin, L., Stephenson, E. A., Howard, T. S., Aziz, P. F., Balaji, S., Ladouceur, V. B., Benson, L. N., Colan, S. D., Godown, J., Henderson, H. T., . . . Mital, S. (2020). A Validated Model for Sudden Cardiac Death Risk Prediction in Pediatric Hypertrophic Cardiomyopathy. Circulation. https://doi.org/10.1161/circulationaha.120.047235

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.